The levels of fasting plasma glucose (FPG), total cholesterol (TC), urea nitrogen (BUN), serum creatinine (SCr), total protein (TP), globulin (GLB), systolic blood pressure (SBP), cystatin C (CysC), transforming growth factor-β (TGF-β), and asymmetric dimethylarginine (ADMA) in the CKD group were significantly higher than those in the controls. The gene discussed is TGFB1; the disease is chronic kidney disease.